Conclusion:
Hypercoagulability and severe inflammatory stress leading to life-threatening illness is a significant complication of COVID-19 infection. There should be a low threshold of suspecting and treating hypercoagulability and inflammation-induced myocardial ischemia and injury with cardiogenic shock. Early recognition and management would be an appropriate strategy to decrease acute as well as chronic morbidity and mortality.
Acknowledgment : None Declared by authors
Source of funding: None